Man Group’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $27.7M | Sell |
986,121
-1,539,479
| -61% | -$41M | 0.05% | 382 |
|
|
2025
Q4 | $62.9M | Sell |
2,525,600
-1,556,514
| -38% | -$39.3M | 0.11% | 204 |
|
|
2025
Q3 | $104M | Buy |
4,082,114
+2,791,848
| +216% | +$68.9M | 0.18% | 128 |
|
|
2025
Q2 | $31.3M | Sell |
1,290,266
-633,634
| -33% | -$14.8M | 0.06% | 357 |
|
|
2025
Q1 | $48.8M | Sell |
1,923,900
-1,283,757
| -40% | -$33.6M | 0.12% | 198 |
|
|
2024
Q4 | $85.1M | Buy |
3,207,657
+251,382
| +9% | +$6.82M | 0.22% | 102 |
|
|
2024
Q3 | $85.6M | Buy |
2,956,275
+1,381,261
| +88% | +$40.3M | 0.22% | 104 |
|
|
2024
Q2 | $44.1M | Sell |
1,575,014
-1,413,720
| -47% | -$38.9M | 0.11% | 208 |
|
|
2024
Q1 | $82.9M | Buy |
2,988,734
+2,247,138
| +303% | +$62.4M | 0.21% | 107 |
|
|
2023
Q4 | $21.4M | Buy |
+741,596
| New | +$22.4M | 0.06% | 385 |
|
|
2023
Q3 | – | Sell |
-684,242
| Closed | -$24.2M | – | 260 |
|
|
2023
Q2 | $25.1M | Buy |
+684,242
| New | +$26.6M | 0.08% | 317 |
|
|
2023
Q1 | – | Sell |
-1,798,785
| Closed | -$77.7M | – | 232 |
|
|
2022
Q4 | $92.2M | Buy |
1,798,785
+942,135
| +110% | +$45.2M | 0.33% | 56 |
|
|
2022
Q3 | $37.5M | Buy |
+856,650
| New | +$41.6M | 0.17% | 144 |
|
|
2022
Q2 | – | Sell |
-2,253,947
| Closed | -$115M | – | 109 |
|
|
2022
Q1 | $117M | Buy |
2,253,947
+1,680,347
| +293% | +$87.2M | 0.41% | 40 |
|
|
2021
Q4 | $33.9M | Sell |
573,600
-754,058
| -57% | -$37.4M | 0.11% | 208 |
|
|
2021
Q3 | $57.1M | Sell |
1,327,658
-1,118,458
| -46% | -$49.5M | 0.2% | 108 |
|
|
2021
Q2 | $95.8M | Buy |
2,446,116
+1,351,189
| +123% | +$52.5M | 0.34% | 56 |
|
|
2021
Q1 | $39.7M | Buy |
1,094,927
+438,789
| +67% | +$15.6M | 0.17% | 129 |
|
|
2020
Q4 | $24.2M | Sell |
656,138
-1,423,320
| -68% | -$52.2M | 0.11% | 188 |
|
|
2020
Q3 | $72.4M | Buy |
2,079,458
+1,059,406
| +104% | +$37.1M | 0.28% | 70 |
|
|
2020
Q2 | $31.6M | Sell |
1,020,052
-125,779
| -11% | -$4.27M | 0.16% | 121 |
|
|
2020
Q1 | $35.5M | Buy |
1,145,831
+701,348
| +158% | +$23.9M | 0.23% | 94 |
|
|
2019
Q4 | $16.5M | Buy |
444,483
+135,503
| +44% | +$4.83M | 0.05% | 428 |
|
|
2019
Q3 | $10.5M | Sell |
308,980
-115,319
| -27% | -$4.19M | 0.04% | 565 |
|
|
2019
Q2 | $17.4M | Sell |
424,299
-44,372
| -9% | -$1.76M | 0.06% | 387 |
|
|
2019
Q1 | $18.9M | Sell |
468,671
-173,959
| -27% | -$6.97M | 0.07% | 333 |
|
|
2018
Q4 | $26.6M | Sell |
642,630
-189,627
| -23% | -$7.87M | 0.12% | 183 |
|
|
2018
Q3 | $34.8M | Buy |
832,257
+72,343
| +10% | +$2.78M | 0.13% | 156 |
|
|
2018
Q2 | $26.2M | Sell |
759,914
-120,761
| -14% | -$4.13M | 0.11% | 193 |
|
|
2018
Q1 | $29.7M | Buy |
+880,675
| New | +$30.3M | 0.14% | 138 |
|
Other funds holding PFE
VCM
VPM
Man Group's PFE Position: Q1 2026 in Review
Man Group reduced its Pfizer (PFE) stake by 61% in Q1 2026, selling an estimated $41M and leaving 986,121 shares worth $27.7M. The position accounts for 0.05% of the portfolio, ranked #382.
Man Group first reported a position in PFE in Q1 2018 and has held it in 30 quarters since. The position peaked at $117M in Q1 2022. 2,937 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Man Group held 986,121 shares of Pfizer worth $27.7M as of Q1 2026.
- Man Group sold 1,539,479 Pfizer shares in Q1 2026, an estimated $41M.
- Pfizer made up 0.05% of Man Group's portfolio in Q1 2026, its #382 holding.
- Man Group first reported a position in Pfizer in Q1 2018 and has held it in 30 quarters since.
- Man Group's Pfizer position peaked at $117M in Q1 2022.
- 2,937 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Man Group's 13F filing for Q1 2026, filed 15 May 2026.